EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation



RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation



Journal of Biological Chemistry 282(23): 16776-16782



Inflammation is a homeostatic mechanism that limits the effects of infectious agents. Tumor necrosis factor (TNF) and interleukin (IL)-1 are two cytokines that induce inflammation through activation of the transcription factor NF-kappa B. Various studies have suggested that two homologous and structurally related adapter proteins TAB2 and TAB3 play redundant roles in TNF- and IL-1-mediated NF-kappa B activation pathways. Both TAB2 and TAB3 contain CUE, coiled-coil, and nuclear protein localization 4 zinc finger (NZF) domains. The NZF domains of TAB2/ 3 are critical for TAB2/ 3 to bind to Lys63-linked polyubiquitin chains of other adaptor proteins, such as receptor-interacting protein and TRAF6, which are two signaling proteins essential for TNF- and IL-1-induced NF-kappa B activation, respectively. In a search for proteins containing NZF domains conserved with those of TAB2/ 3, we identified RBCK1, which has been shown to act as an E3 ubiquitin ligase in iron metabolism. Overexpression of RBCK1 negatively regulates TAB2/ 3-mediated and TNF- and IL-1-induced NF-kappa B activation, whereas knockdown of RBCK1 by RNA interference potentiates TNF- and IL-1-induced NF-kappa B activation. RBCK1 physically interacts with TAB2/ 3 and facilitates degradation of TAB2/ 3 through a proteasome-dependent process. Taken together, our findings suggest that RBCK1 is involved in negative regulation of inflammatory signaling triggered by TNF and IL-1 through targeting TAB2/ 3 for degradation.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333612

Download citation: RISBibTeXText

PMID: 17449468

DOI: 10.1074/jbc.M701913200



Related references

RBCK1 Negatively Regulates Tumor Necrosis Factor- and Interleukin-1-triggered NF-kB Activation by Targeting TAB2/3 for Degradation. The Journal of Biological Chemistry 282(23): 776-82, 2007

TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nature Immunology 9(4): 369-377, 2008

The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. Journal of Experimental Medicine 198(12): 1959-1964, 2003

IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway. Journal of Biological Chemistry 273(12): 6607-6610, 1998

The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1. Journal of Biological Chemistry 288(2): 819-825, 2013

Acute alcohol inhibits induction of nuclear regulatory factor kappaB activation through CD/14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors independent of IkappaBalpha degradation. Alcoholism Clinical & Experimental Research 27(5 Supplement): 88A, 2003

IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Journal of Biological Chemistry 273(12): 6607-6610, March 20, 1998

Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Molecular and Cellular Biology 17(11): 6746-6754, 1997

Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Antioxidants & Redox Signaling 2(1): 83-92, 2001

MicroRNA-218 Negatively Regulates Osteoclastogenic Differentiation by Repressing the Nuclear Factor-B Signaling Pathway and Targeting Tumor Necrosis Factor Receptor 1. Cellular Physiology and Biochemistry 48(1): 339-347, 2018

Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors. Journal of Bone and Mineral Research 16(7): 1272-1280, 2001

Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription. Journal of Biological Chemistry 274(28): 19965-19972, 1999

Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. Journal of Biological Chemistry 272(41): 25941-25950, 1997

Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochemical and Biophysical Research Communications 258(2): 443-447, 1999

Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. Journal of Biological Chemistry 279(1): 677-685, 2003